Position in VIR
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$2,186,050
+$980,509 QoQ
Shares Held
214,529
+59.4% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2
of 38 holders
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $205,108,253 across 117 Biotechnology names. VIR ranks #35 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
101,908 | $10,865,430 | |
| 2 | MRNA |
Moderna, Inc.
|
139,861 | $9,794,465 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
107,419 | $8,000,567 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
22,923 | $5,610,862 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
67,374 | $5,342,084 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
573,581 | $4,800,872 | |
| 7 | UPB |
Upstream Bio, Inc.
|
693,555 | $4,799,400 | |
| 8 | NRIX |
Nurix Therapeutics, Inc.
|
192,434 | $4,668,448 |
All Filings in VIR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,186,050 | 214,529 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,205,541 | 134,547 | Shares | Sole | 2026-04-27 | |
| 2025-03-31 | $168,953 | 26,073 | Shares | Sole | 2025-05-06 | |
| 2024-09-30 | $168,187 | 22,455 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $925,146 | 103,949 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $185,581 | 18,320 | Shares | Sole | 2024-05-10 | |
| 2023-09-30 | $396,032 | 42,266 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $895,266 | 38,473 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $876,662 | 34,637 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $314,656 | 12,354 | Shares | Sole | 2022-08-08 | |
| No filing history on record for this holder in this stock. | ||||||